Exact Sciences Corporation (EXAS)
Mar 23, 2026 - EXAS was delisted (reason: acquired by ABT)
104.91
+0.99 (0.95%)
Inactive · Last trade price on Mar 20, 2026
Exact Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -207.95 | -1,029 | -204.15 | -623.51 | -595.63 |
Depreciation & Amortization | 221.58 | 214.86 | 206.61 | 197.56 | 180.35 |
Loss (Gain) From Sale of Assets | - | - | - | 13.24 | - |
Asset Writedown & Restructuring Costs | 82.2 | 869.46 | 1.12 | 15.97 | 105.55 |
Loss (Gain) From Sale of Investments | -3.08 | 2.71 | -4.1 | 21.77 | -29.01 |
Stock-Based Compensation | 217.67 | 214.89 | 231.31 | 206.82 | 253.06 |
Other Operating Activities | 59.2 | -6.51 | -74.33 | -29.04 | -127.67 |
Change in Accounts Receivable | -48.89 | -46.26 | -43.42 | 61.09 | 25.15 |
Change in Inventory | -3.77 | -34.91 | -7.69 | -13.23 | -9.22 |
Change in Accounts Payable | 214.04 | 43.54 | 82.75 | -52.18 | 169.8 |
Change in Other Net Operating Assets | -39.55 | -18.38 | -31.99 | -22.05 | -74.62 |
Operating Cash Flow | 491.44 | 210.54 | 156.12 | -223.56 | -102.24 |
Operating Cash Flow Growth | 133.42% | 34.86% | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -134.66 | -135.99 | -124.19 | -214.46 | -135.77 |
Sale of Property, Plant & Equipment | - | - | - | 25 | - |
Cash Acquisitions | -75 | -45 | -52.91 | -14.69 | -557.8 |
Investment in Securities | 376.51 | -260.94 | 226.53 | 278.76 | -387.77 |
Other Investing Activities | 28.27 | -0.23 | 0.25 | -0.55 | -0.74 |
Investing Cash Flow | 195.12 | -442.16 | 49.68 | 74.07 | -1,082 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 266.75 | 137.98 | 50 | - |
Long-Term Debt Repaid | -249.17 | -50 | - | - | -23.75 |
Net Debt Issued (Repaid) | -249.17 | 216.75 | 137.98 | 50 | -23.75 |
Issuance of Common Stock | 28.45 | 32.88 | 31.54 | 32.02 | 37.51 |
Other Financing Activities | -117.36 | -17.75 | -9.75 | -5.53 | -5.29 |
Financing Cash Flow | -338.09 | 231.87 | 159.77 | 76.49 | 8.47 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.89 | -3.29 | 1.32 | 0.03 | 0.02 |
Net Cash Flow | 349.36 | -3.04 | 366.89 | -72.98 | -1,176 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 356.78 | 74.55 | 31.93 | -438.02 | -238 |
Free Cash Flow Growth | 378.60% | 133.48% | - | - | - |
Free Cash Flow Margin | 10.99% | 2.70% | 1.28% | -21.02% | -13.47% |
Free Cash Flow Per Share | 1.89 | 0.41 | 0.18 | -2.48 | -1.39 |
Levered Free Cash Flow | 281.87 | 50.83 | 91.77 | -283.12 | 79.2 |
Unlevered Free Cash Flow | 306.47 | 74.12 | 103.92 | -270.85 | 90.83 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 30.44 | 27.84 | 18.78 | 11.52 | 10.74 |
Change in Working Capital | 121.83 | -56.01 | -0.34 | -26.38 | 111.11 |